Home

Versant Venture Capital IV, L.P.

CIK 1456590 · last filed 2019-01-16

Versant Venture Capital IV, L.P. is a corporate insider who has filed 3 SEC Form 4 insider transactions across 3 companies since 2011. The most recent filing, for OPHT, was dated Jan 16, 2019. The firm reports its address in San Francisco, CA. 29 SEC filings were submitted jointly with Versant Side Fund IV, L.P.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

3

Total Filings

3

Lifetime Open-Market Net

$0

Filer Profile

Reported Address
ONE SANSOME STREET
SUITE 1650
SAN FRANCISCO, CA 94104
Phone
(650) 233-2211
State of Incorporation
DE
Related Filers
Versant Side Fund IV, L.P. — 29 joint filings, latest 2024-08-12
Versant Ventures IV, LLC — 27 joint filings, latest 2024-08-12
Versant Venture Capital VI, L.P. — 14 joint filings, latest 2024-08-12
Versant Ventures VI GP, L.P. — 14 joint filings, latest 2024-08-12
Versant Ventures VI GP-GP, LLC — 14 joint filings, latest 2024-08-12
Versant Vantage I GP, L.P. — 11 joint filings, latest 2024-04-11
Versant Vantage I GP-GP, LLC — 11 joint filings, latest 2024-04-11
Versant Vantage I, L.P. — 11 joint filings, latest 2024-04-11
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
IVERIC bio, Inc. (OPHT) Delisted 10%+ Owner 32,394 — — $0 1 2019-01-16
CRISPR Therapeutics AG (PZRX) Delisted 10%+ Owner 2,443,803 — — $0 1 2016-10-26
Clovis Oncology, Inc. (CLVS) Delisted 10%+ Owner 2,159,289 $0.08 $175.3K $0 1 2011-11-17

Recent Filings

3 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2019-01-16 IVERIC bio, Inc. (OPHT) Delisted Other (J) +391,578 $900.0K EDGAR
2016-10-26 CRISPR Therapeutics AG (PZRX) Delisted Grant (A) +644,000 $9.02M EDGAR
2011-11-17 Clovis Oncology, Inc. (CLVS) Delisted Mixed +1,996,464 $0 EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.